We’re excited to reveal that team ILLUMINE led by Reuven Agami has been selected by Cancer Grand Challenges to to take on one of cancer’s toughest challenges. Congratulations to Reuven and all the #CancerGrandChallenges teams! ➡️nki.nl/news-events/news/illuminating-cancer-s-hidden-layer/

INDIBLADE (phase II): testing the concept of organ preservation enabled by powerful induction therapy in muscle-invasive bladder cancer. High 2-year bladder-intact event-free survival with induction immunotherapy + CRT. Now in Nature Medicine: www.nature.com/articles/s41...

🎉 Congratulations to @zwartlab.bsky.social on receiving a Vici grant from NWO Dutch Research Council for PERSEUS. Exploring how gene regulation rewires prostate cancer and how to turn those insights into targeted therapies. www.nwo.nl/en/news/39-r...

We;re hiring Junior Group Leaders! 🔬✨ We’re looking for researchers in immunology, chemical biology, AI in biology, or protein design to launch their own independent groups in our collaborative, international environment. www.nki.nl/news-events/...

We are part of @eu-life.bsky.social together with research institutes across Europe we want to strengthen research & innovation and be a voice for research in European policy This series highlights our shared priorities. This time #Internationality🌍 Stay tuned for the NKI’s story #WeAreEULife

Postdoc alert in spatial biology! Building upon our previous work with MSI cancers (e.g. de Vries et al, Nature, 2023), the Voest Group at the NKI is hiring a (fully funded) postdoctoral fellow with strong expertise in spatial cancer biology. Learn more / apply here: www.nki.nl/careers-stud...

💡“DEprot” is now out on @narjournal.bsky.social Genomics and Bioinformatics. With Nils Eickhoff ( @zwartlab.bsky.social, @nkinl.bsky.social & @oncodeinstitute.bsky.social), we designed this “all-in-one” tool to facilitate the analyses of LFQ-based proteomics data. academic.oup.com/nargab/artic...

What better day than International Day of Women & Girls in Science to announce that The International Neuropsychological Society has awarded Sanne Schagen a Lifetime Award for Research?

Researchers discovered that the way immune cells and cancer cells are organized inside ovarian tumors can make a difference to how long patients live ➡️ nki.nl/news-events/news/new-study-maps-ovarian-cancer-s-immune-landscape-and-reveals-key-marker-linked-to-survival/

Pastry chef Müller brightened our day by delivering no fewer than 2,000 cream puffs for employees of the Netherlands Cancer Institute 🧁 Each year, Müller runs a campaign in which a donation is made to the Mike Multi Foundation for every cream puff sold. Thank you!

Out now in @natureportfolio.nature.com: PARM reveals gene regulation is far more predictable than thought. Lightweight, cell‑type specific, and experimentally validated. Enables functional prediction of regulatory mutations with just one dish of cells + one day of compute. ➡️ doi.org/10.1038/s415...

It’s amazing how much one can discover about a single protein. In the case of PhD candidate Niels Keijzer, that protein is USP1. During his PhD he unraveled several of its secrets ➡️ www.nki.nl/news-events/...

Why do patients with liver metastases respond so poorly to cancer immunotherapy? Here we find a new immunological mechanism in MMR-d cancers centering on IL-18 and γδ T cells.👇 www.cell.com/cell-reports... @cp-cellrepmed.bsky.social

Congratulations @sarahmoser.bsky.social 🎊

Good news for many: women with breast cancer who receive silicone implants don’t have a higher risk of symptoms linked to Breast Implant Illness, concludes PhD candidate Jonathan Spoor based on a large Dutch study involving over 6,000 women ➡️ www.nki.nl/news-events/...

🎓 Our immune system has an effect on the tumor, and vice versa. It is more active in metastatic cancer. PhD candidate Noor Bakker sees major differences, especially in patients with triple-negative breast cancer. www.nki.nl/news-events/...

As per January German-English scientist Natalie Scholes (32) will start her own research group at the Netherlands Cancer Institute! ➡️ nki.nl/news-events/news/chemical-matchmaker-in-search-of-societal-impact-natalie-scholes-starts-research-group-at-the-netherlands-cancer-institute/ #NKI #research

🎉 Group Leader Leila Akkari @leilaakkari.bsky.social has been appointed Professor of Cancer-Immune Interactions at Leiden University. Congratulations Leila! www.nki.nl/news-events/...

🐭 In vivo veritas 🐭 Now out in Nature Genetics: @josjonkers.bsky.social and I describe currently available mouse models of BRCA1/2 and their roles in understanding BRCA1/2 biology, particularly in normal development, tumor suppression and therapy response. www.nature.com/articles/s41...

✨ Happy New Year! ✨ As we step into 2026, we want to thank all of you for being part of our journey in 2025. Together, we’ve achieved incredible milestones we’re looking forward to continuing to make a difference in cancer research. Let’s make 2026 a year of collaboration, innovation and inspiration

Inspired by an initiative from OLVG Hospital, team leaders, managers and directors stepped into care roles during Operation Oliebol including Henri van Luenen & @vanrheenenlab.bsky.social Not because they had to, but to support colleagues working on New Year’s Eve

🎓 There are more and more options for breast-conserving treatment for breast cancer patients. However, PhD candidate Eva Heeling shows that aren’t offered the same options across all hospitals. More: www.nki.nl/news-events/...

Eleven research teams at the Netherlands Cancer Institute are starting new cancer projects thanks to funding from the Dutch Cancer Society. From personalized therapies to smarter detection, these projects push science closer to patients. Thank you KWF ❤️💙 Learn more: www.nki.nl/news-events/...

Corticosteroids may re-sensitize metastatic HR+ breast cancer to endocrine therapy by mimicking cortisol-driven fasting responses. Our study, published in Nature, shows a potential new use for a cheap and widely used drug class. ➡️ www.nki.nl/news-events/...

Cells appear as chaotic as a big city, but transcription factors behave like packages and are usually delivered smoothly. PhD candidate Jos Meeussen was able to track-and-trace them under his microscope: www.nki.nl/news-events/...

💡Welcome to #EULIFEspotlight! This month we celebrate Henri van Luenen, Director of Operations at @nkinl.bsky.social, who moderated the session “Research security in practice: making space for an honest conversation”, organised by EU-LIFE at the EU Conference on #ResearchSecurity 🔗 bit.ly/4hPXbhw

Joost Agelink van Rentergem received a Vidi grant for research on cognitive impairment ➡️ www.nki.nl/news-events/...

Last Thursday I defended my PhD at @erasmusmc.bsky.social Thank you so much to all that joined the defence and to @maxkoppers.bsky.social, @madelonmaurice.bsky.social, Celia Berkers and Vered Raz for the great scientific discussion.

Honored to welcome Prof. Charles Swanton for this year’s Piet Borst Lecture ✨ The afternoon opened with a beautiful cello intermezzo 🎻 Inspiring from start to finish.”

A new @nature.com.web.brid.gy paper by @peeperlab.bsky.social shows that T cells that cling to cancer cells are the most potent killers. These clusters, long overlooked, can be isolated directly from tumors www.nature.com/articles/s41...

Our new paper is out in Nature - online today! Huge congrats to shared first authors Sofía Ibáñez-Molero & Johanna Veldman, the whole team & all collaborators. 📄 Open-access paper: www.nature.com/articles/s41...

At the end of the rainbow 🌈 📷 Zowi Huinen

🎓 Patients who survived (non-)Hodgkin lymphoma have a higher risk of cardiovascular diseases or subsequent malignancies. Yvonne Geurts successfully defended her thesis showing that that a better understanding of these risks contributed to improved & risk-based follow-up care. Congratulations Yvonne!

Ribosomes are just like people. They are diverse, they can dance, collide, and experience stress. During stress, the translation process plays a key role in the development of cancer, a discovery made by PhD candidate Sofia Ramalho ➡️ www.nki.nl/news-events/... @sofiaramalho.bsky.social

How can we detect cancer earlier? Early detection of cancer often leads to less invasive treatment and increased chance of recovery. That’s why our researchers and physicians work hard to answer this question. Learn more about their search in this video ➡️ www.youtube.com/watch?v=sa1M...

During the replication process, cells can hit the pause button if something goes wrong, before starting the next phase. PhD candidate Frank van Gemert identified a protein that plays a key role. ➡️ www.nki.nl/news-events/...

Congratulations to @benjaminrowland.bsky.social for receiving an @erc.europa.eu Synergy Grant together with TU Delft, University of Edinburgh and @mit.edu / @institutcurie.bsky.social he will work on the GeneMotors project to unravel how SMC proteins pull DNA into loops. More: bit.ly/4osZjOJ

Thanks to support from the Dutch Cancer Society , researcher Marjanka Schmidt and her team are expanding the Hebon study to include more and more diverse participants in hereditary breast and ovarian cancer research. More: www.nki.nl/news-events/...

Proud! Our scientific director Thijn Brummelkamp was a guest at the “Uitblinkerslunch” (Lunch for Outstanding Achievers) hosted by King Willem-Alexander and Queen Máxima.

What a great recognition for our inspiring scientist and professor Karin de Visser: she received the Josephine Nefkens Prize 2025. Congratulations Karin! 🎉 #NKI #fundamentalresearch #cancerresearch #oncology #breastcancer #cancerimmunology

The results of the SUPREMO trial are in and published in @nejm.org. Results show that radiotherapy can be safely omitted as a treatment for many breast cancer patients who have had a mastectomy and were treated with anti-cancer drugs ➡️ www.nki.nl/news-events/...

🚀 We’re hiring! Join our team at the NKI as a Postdoc, using Quantitative Membrane Proteomics to design novel cancer immunotherapies! Best of two worlds from the Voest and Lindeboom Labs. Cutting-edge proteomics, translational immunotherapy and world-class instrumentation? let’s connect! 🔬💡

Thanks to KWF Dutch Cancer Society Esther Lips and her colleagues will be able to continue their search to find out which women with DCIS will require treatment and which do not ➡️ www.nki.nl/news-events/...

#EANO2025 was a blast! Thanks to the travel grant of the Utrecht CEN PhD program, I could present our work on the blood-brain barrier in brain metastases 🧠🔬

Are you excited to uncover the molecular mechanisms of actin filament assemblies that drive cell migration using cryo-EM? Only 1.5 week to apply for this exciting PhD position in my newly established lab at the Netherlands Cancer Institute in Amsterdam: www.werkenbijavl.nl/vacatures/ph...

What if parts of our DNA accidentally end up in the wrong place? What can be bad for healthy cells could be an advantage for tumor cells, observed PhD candidate Soufyan Lakbir, who loves his experiments. Soufyan Lakbir will defend his thesis on October 29 ➡️ www.nki.nl/news-events/...

Big congrats to the MARI team for winning the NKI Patient Impact Award! Their work helps breast cancer patients avoid unnecessary surgery. 💙 #NKI #BreastCancer #Innovation Read more ➡️ www.nki.nl/news-events/...

#ESMO2025 kicks off in Berlin! Our NKI team is in Berlin to share research, lead discussions, and connect with oncology experts from around the world. 💙 #Oncology #CancerResearch See all NKI input: bit.ly/4okZxXF

🧬 We are very proud: Our scientific director @thijnbrummel.bsky.social has received the Spinoza Prize, the highest distinction in Dutch science. Thijn’s groundbreaking genetic research helps uncover how cancer cells work ➡️ bit.ly/494IXXH #SpinozaPrize #Science #Research #Innovation #CancerResearch

🎓 Immunotherapy for liver tumors seems almost impossible, but PhD candidate Christel Ramirez @unileiden.bsky.social discovered a way to prevent immune cells from being ‘bribed’ by cancer cells. She will defend her thesis on October 15 ➡️ www.nki.nl/news-events/...